Incyte (INCY) - P/S ratio

P/S ratio as of November 2026 (TTM): 4.13

According to Incyte's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.40. At the end of 2023 the company had a P/S ratio of 3.81.

P/S ratio history for Incyte from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	3.81	-27.67%
2022	5.26	-3.05%
2021	5.43	-23.99%
2020	7.14	-18.31%
2019	8.74	21.33%
2018	7.21	-44.61%
2017	13.0	-23.84%
2016	17.1	-36.39%
2015	26.9	9.95%
2014	24.4	5.06%
2013	23.2	211.53%
2012	7.46	-62.82%
2011	20.1	67.01%
2010	12.0	-89.72%
2009	117	24.43%
2008	93.9	280.86%
2007	24.7	39.05%
2006	17.7	-68.82%
2005	56.9	-26.13%
2004	77.0	630.92%
2003	10.5	249.52%
2002	3.01	-49.06%
2001	5.92

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Novartis NVS	5.39	30.38%	🇨🇭 Switzerland
Pfizer PFE	2.62	-36.72%	🇺🇸 USA
Eli Lilly LLY	14.5	251.91%	🇺🇸 USA
Amgen AMGN	6.61	59.81%	🇺🇸 USA
Ligand Pharmaceuticals LGND	21.6	423.25%	🇺🇸 USA
Geron GERN	3.14	-24.07%	🇺🇸 USA
CTI BioPharma CTIC	15.8	282.77%	🇺🇸 USA
AVEO Oncology AVEO	5.53	33.75%	🇺🇸 USA
Ardelyx ARDX	1.63	-60.48%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Incyte (INCY)

P/S ratio as of November 2026 (TTM): 4.13